What is the optimal biological therapy for moderate to severe ulcerative colitis: a systematic review and network meta-analysis

ObjectiveThe biologics for moderate to severe ulcerative colitis (UC) have expanded with an increasing array. We performed an updated network meta-analysis to evaluate and compare the relative efficacy and safety profiles of biologics in moderate to severe UC.DesignWe searched literature to 18 May 2...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Longbin Huang, Chen Kong, Ningning Yue, Hailan Zhao, Yuan Zhang, Chengmei Tian, Zhiliang Mai, Daoru Wei, Ruiyue Shi, Jun Yao, Lisheng Wang, Defeng Li
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Frontiers Media S.A. 2025-07-01
Sarja:	Frontiers in Pharmacology
Aiheet:	ulcerative colitis biological therapy clinical trials bayesian network meta-analysis systematic review
Linkit:	https://www.frontiersin.org/articles/10.3389/fphar.2025.1602024/full
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!